These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 17072128

  • 1. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R, Hutton N, Siberry GK.
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [Abstract] [Full Text] [Related]

  • 2. Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir.
    Bhumbra NA, Sahloff EG, Oehrtman SJ, Horner JM.
    Ann Pharmacother; 2007 Jul; 41(7):1306-9. PubMed ID: 17535841
    [Abstract] [Full Text] [Related]

  • 3. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
    Foisy MM, Yakiwchuk EM, Chiu I, Singh AE.
    HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946
    [Abstract] [Full Text] [Related]

  • 4. Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy.
    Gupta SK, Dubé MP.
    Clin Infect Dis; 2002 Sep 15; 35(6):E69-71. PubMed ID: 12203188
    [Abstract] [Full Text] [Related]

  • 5. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen.
    Clevenbergh P, Corcostegui M, Gérard D, Hieronimus S, Mondain V, Chichmanian RM, Sadoul JL, Dellamonica P.
    J Infect; 2002 Apr 15; 44(3):194-5. PubMed ID: 12099750
    [Abstract] [Full Text] [Related]

  • 6. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.
    Valin N, De Castro N, Garrait V, Bergeron A, Bouche C, Molina JM.
    J Int Assoc Physicians AIDS Care (Chic); 2009 Apr 15; 8(2):113-21. PubMed ID: 19270151
    [Abstract] [Full Text] [Related]

  • 7. Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.
    Temple ME, Koranyi KI, Nahata MC.
    Ann Pharmacother; 2003 Sep 15; 37(9):1214-8. PubMed ID: 12921501
    [Abstract] [Full Text] [Related]

  • 8. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
    Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Lujan-Zilbermann J.
    J Pediatr; 2006 Mar 15; 148(3):386-8. PubMed ID: 16615973
    [Abstract] [Full Text] [Related]

  • 9. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K, Asher I, Gradstein S, Zung A, Radian-Sade S, Elbirt D, Sthoeger Z.
    J Asthma; 2011 Oct 15; 48(8):860-3. PubMed ID: 21854345
    [Abstract] [Full Text] [Related]

  • 10. Ritonavir and fluticasone: beware of this potentially fatal combination.
    Li AM.
    J Pediatr; 2006 Mar 15; 148(3):294-5. PubMed ID: 16615953
    [No Abstract] [Full Text] [Related]

  • 11. [Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone].
    Machala L, Kréze A, Jilich D, Rozsypal H.
    Klin Mikrobiol Infekc Lek; 2011 Jun 15; 17(3):103-5. PubMed ID: 21780031
    [Abstract] [Full Text] [Related]

  • 12. Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS.
    Jinno S, Goshima C.
    AIDS Read; 2008 Feb 15; 18(2):100-4. PubMed ID: 18333287
    [Abstract] [Full Text] [Related]

  • 13. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
    St Germain RM, Yigit S, Wells L, Girotto JE, Salazar JC.
    AIDS Patient Care STDS; 2007 Jun 15; 21(6):373-7. PubMed ID: 17594245
    [Abstract] [Full Text] [Related]

  • 14. Cushing syndrome due to ritonavir-fluticasone interaction.
    Canalejo E, Pacheco MS.
    CMAJ; 2012 Oct 16; 184(15):1714. PubMed ID: 22586335
    [No Abstract] [Full Text] [Related]

  • 15. [Fluticasone-ritonavir: a drug-drug interaction causing iatrogenic Cushing's syndrome and adrenal insufficiency].
    Rousseau C, Dolz M.
    Med Mal Infect; 2014 Oct 16; 44(10):483-4. PubMed ID: 25282607
    [No Abstract] [Full Text] [Related]

  • 16. Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir.
    Danaher PJ, Salsbury TL, Delmar JA.
    Orthopedics; 2009 Jun 16; 32(6):450. PubMed ID: 19634808
    [Abstract] [Full Text] [Related]

  • 17. Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone.
    Chen F, Kearney T, Robinson S, Daley-Yates PT, Waldron S, Churchill DR.
    Sex Transm Infect; 1999 Aug 16; 75(4):274. PubMed ID: 10615321
    [No Abstract] [Full Text] [Related]

  • 18. Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. Case report and literature review.
    Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM.
    AIDS; 2007 Feb 19; 21(4):529-32. PubMed ID: 17301576
    [No Abstract] [Full Text] [Related]

  • 19. Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction.
    Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J.
    Intern Med J; 2005 Jan 19; 35(1):67-8. PubMed ID: 15667475
    [No Abstract] [Full Text] [Related]

  • 20. [Iatrogenic Cushing syndrome in an HIV-infected female patient: be careful about interaction inhaled corticosteroids-ritonavir!].
    Bouldouyre MA, Moachon L, Guillevin L, Launay O.
    Presse Med; 2008 Dec 19; 37(12):1834-5. PubMed ID: 18926662
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.